The study, by the Florida Society of Interventional Pain Physicians, evaluated mild patients six weeks following the procedure using the Zurich Claudication Questionnaire. Patients rated their overall satisfaction at a 2.02 on a scale from 1 to 4, with 1 being the highest score.
Vertos mild is FDA-approved for treating central canal stenosis of the lumbar spine.
Read the Vertos release on the MiDAS I clinical trial (pdf).
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
